02637

海西新藥

237.600

+24.600+11.55%
Closed16:08 04/24 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE237.000/237.600
TODAY RANGE237.000-284.600
VOL499.00K
MARKET CAP21.93B
52 WEEK RANGE97.500-284.600
AVG VOL (3M)258.36K
% TURNOVER0.63%
TURNOVER133.29M
P/E (TTM)111.879
% RANGE20.03%
EPS(TTM)2.490
P/E(FORWARD)--
P/B12.427
BVPS22.419
DIVIDEND--
P/S34.010
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP21.93B
SHARES OUTSTANDING78.71M
NEXT EARNINGS--
FREE FLOAT78.71M
LOT SIZE50
EX-DATE--
Same Industry
Name/Symbol
Change%
Price

04332

--

藥明康德

02359

+0.82%
123.700

海螺創業

00586

+1.23%
11.560

A

Asymchem Laboratories (Tianjin)

06821

+7.98%
99.400

國藥控股

01099

-1.74%
19.220

G

Guangzhou Baiyunshan Pharmaceutical Holdings

00874

+0.12%
16.800

麗珠醫藥

01513

+1.00%
28.340

上海醫藥

02607

-0.34%
11.820

復星醫藥

02196

-0.40%
20.140

康哲藥業

00867

-2.62%
13.370

06600

--

W

Wuxi Biologics (Cayman)

02269

-1.18%
33.520

中國同輻

01763

+0.91%
18.830

神威藥業

02877

-2.27%
9.900

聯邦制藥

03933

+1.13%
9.850

康臣葯業

01681

+1.15%
15.840

三生製藥

01530

+2.80%
22.760

山東新華製藥股份

00719

-0.32%
6.290

同仁堂國藥

03613

-0.27%
7.520

C

China Resources Pharmaceutical Group

03320

-1.03%
5.780

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.